Table 3.
Comparison of metabolic profile in NAFLD patients with and without IBD
| Variables | NAFLD + IBD (N = 78) | NAFLD w/o IBD (N = 145) | p-value |
|---|---|---|---|
| Weight, mean ± SD, Kg | 78.1 ± 13.3 | 82.3 ± 15.8 | 0.04 1 |
| Waist circumference, mean ± SD, cm | 97.7 ± 14 | 102 ± 14.5 | 0.04 1 |
| BMI, mean ± SD, Kg/m2 | 28.63 ± 4.83 | 30.22 ± 5.38 | <0.001 1 |
| Obesity, n (%) | 21 (26.9%) | 72 (52.4%) | <0.001 2 |
| Total cholesterol, mean ± SD, mg/dL | 214.25 ± 42.99 | 218.01 ± 43.73 | 0.81 |
| LDL cholesterol, mean ± SD, mg/dL | 133.94 ± 37.1 | 130.24 ± 37.9 | 0.551 |
| HDL cholesterol, mean ± SD, mg/dL | 51.02 ± 14.54 | 49.35 ± 15.40 | 0.481 |
| Triglycerides, mean ± SD, mg/dL | 167.41 ± 88.64 | 143.3 ± 66.7 | 0.921 |
| Elevated TG, n (%) | 22 (29.5%) | 53 (36.6%) | 0.281 |
| Fasting plasma glucose, mean ± SD, mg/dL | 92.67 ± 14.82 | 108.2 ± 32.7 | 0.161 |
| Elevated glucose, n (%) | 23 (29.5%) | 65 (44.8%) | 0.03 2 |
| Insulin, mean ± SD, µIU/mL | 15.92 ± 11.72 | 12.65 ± 6.92 | 0.241 |
| Hypertension, n (%) | 19 (24.4%) | 76 (52.4%) | <0.001 2 |
| Reduced HDL cholesterol, n (%) | 20 (31.2%) | 67 (48.9%) | 0.02 2 |
| Metabolic syndrome, n (%) | 18 (23.1%) | 82 (56.6%) | <0.001 2 |
SD standard deviation, BMI body mass index, LDL low-density level, HDL high-density level, TG triglycerides
1Student’s t-test
2Pearson’s χ2-test or two-tailed Fisher’s exact